Computational immunology specialist with ISPRI platform analyzing 2M sequences/year for immunogenicity risk; founded 1998, 230+ peer-reviewed publications, 9 of top 12 biopharma
UnknownEarly Stage
Total Funding
—
Employees
—
Headquarters
Providence
Founded
1998
About
Categories
Funding History
Round
Amount
Date
Lead Investors
Strategic Investment (Acquired by SV Health Investors)